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Edited by Francesc PosasAbstract ATOH1 is a basic Helix-Loop-Helix transcription
factor crucial for hair cell (HC) diﬀerentiation in the inner ear.
In order to identify ATOH1 target genes, we performed a gen-
ome-wide expression proﬁling analysis in cells expressing
ATOH1 under the control of a tetracycline-oﬀ system and found
that HES6 expression is induced by ATOH1. We performed
in situ hybridisation and showed that the rise and fall of Hes6
expression closely follow that of Atoh1 in cochlear HC. More-
over, electrophoretic mobility shift assays and luciferase assays
show that ATOH1 activates HES6 transcription through bind-
ing to three clustered E boxes of its promoter.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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(Drosophila) protein, mouse1. Introduction
The vertebrate inner ear consists of the cochlea for audition,
and the vestibular end organs including the utricle, saccule and
three semi-circular canals, for balance. Each of these structures
contains a sensory epithelium made of supporting cells and
mechanosensory hair cells (HC) [1]. They are produced by a
prosensory equivalence group located in the zone of non-pro-
liferating cells in the cochlea, initially marked by expression of
the proneural gene Atoh1 (Drosophila atonal homolog 1) [2,3].
As the equivalence group develops, some cells upregulate
Atoh1 expression and complete diﬀerentiation as HC. It has
been shown that ATOH1 is both necessary and suﬃcient for
HC diﬀerentiation [2,4].
ATOH1 belongs to the tissue-speciﬁc class 2 of bHLH (basic
Helix-Loop-Helix) factors which perform their biological func-
tion by forming heterodimers with ubiquitously expressed class
1 bHLH factors such as E12 and E47. The heterodimers bind
to regulatory sequences called E boxes (CAnnTG) and trans-Abbreviations: bHLH, basic Helix-Loop-Helix; EMSA, electrophoretic
mobility shift assay; RT-PCR, reverse transcription-polymerase chain
reaction; bp, base pairs; kb, kilo base; TET, tetracycline; HC, hair
cells; NE, nuclear extract; ISH, in situ hybridisation
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doi:10.1016/j.febslet.2007.08.059criptionally activate their target genes [5]. Only two genes have
been shown to be direct downstream targets of ATOH1:Mbh1
in commissural neurons [6] and Nr2f6 in cerebellar granule cell
progenitors [7]. ATOH1 also regulates its own expression
through binding to a 3 0 located enhancer [8]. Despite its critical
role in development, the molecular mechanisms by which
ATOH1 orchestrates HC diﬀerentiation remain elusive.
HES factors (Hairy-Enhancer of Split homologs) are also
bHLH proteins. HES1 and HES5 are expressed in supporting
cells of the cochlea and non-sensory regions [9,10]. They are
thought to prevent the diﬀerentiation of progenitors of HC
as a result of lateral inhibition. Another HES factor, HES6,
has been recently described in HC [11]. HES6 is unique among
HES factors as it promotes, instead of inhibiting, neuronal and
myogenic diﬀerentiation [12–15] probably through antagoniz-
ing the HES1 and HES5 functions [15,16].
In order to identify ATOH1 target genes, we performed a
genome-wide expression proﬁle analysis in cells expressing
Atoh1 under the control of a tetracycline (TET)-oﬀ system,
and found that HES6 expression is induced by ATOH1. The
rise and fall of HES6 expression during development closely
follow that of Atoh1 in cochlear HC. Moreover, ATOH1 di-
rectly regulates HES6 expression in vitro through binding to
three E boxes of its promoter.2. Materials and methods
All primers used are described in Supplementary Table 1.
2.1. Animal procedures
OF1 and CD1 mice were purchased from Charles River Laborato-
ries. Animal procedures were approved by the Comite Regional d’Ethi-
que pour l’Experimentation Animale.
2.2. Microarray expression analysis
We used U2OS (human osteosarcoma) cells stably transfected
with Atoh1-HA-tagged cDNA under the control of a TET responsive
element (pUHD10-3 vector) [17]. ATOH1 expression is induced by
removing TET. Cells were plated (2 · 106 cells per 10 cm diameter
plate) in the presence of TET for 24 h, then the medium was replaced
with or without TET. After replacing the medium, the experiment was
stopped at t = 8 or 24 h. Total RNA extraction and labelled cRNA
synthesis were performed as recommended by Aﬀymetrix using 1 lg
of total RNA. Data analysis is described in the Supplementary mate-
rial.
2.3. RT-PCR
Stably transfected U2OS cells were grown in DMEM with and with-
out TET for 0, 2, 4, 6, 8 or 24 h before extraction for time-course anal-
ysis of target-gene expression. RNA extractions were performed usingblished by Elsevier B.V. All rights reserved.
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reaction (RT-PCR) using Superscript II and Taq polymerase (Invitro-
gen).
2.4. Plasmid constructs
The mouse Atoh1 coding sequence was cloned in the pCMV-sport6
expression vector. The E47 cDNA inserted into the same vector was
purchased as I.M.A.G.E. clone #4505427. The 1.2 kilo base (kb)
HES6 promoter was cloned into pXP1 (GenBank GI:3929277). See
supplementary data for more details. The E boxes were mutated as
in EMSA probes (see Supplementary data) by site-directed mutagene-
sis (Quik-Change, Stratagene). ISH probes were cloned into the
pCRII-Topo vector (Invitrogen).
2.5. Cell culture
U2OS cells were grown in DMEM + 10% FCS + 1 mg/ml TET.
Transfection and luciferase assays were carried out as previously de-
scribed [18]. Each condition was performed in duplicate and results
presented here are the mean of four experiments. Nuclear extracts
(NEs) were prepared in HeLa cells as previously described [18], then
characterized by Western Blot using monoclonal anti-mouse
MATH1/ATOH1 (Hybridoma bank) and rabbit polyclonal anti-E47
(N-649, Santa Cruz Biotechnology Inc.) antibodies.
2.6. EMSA
Electrophoretic mobility shift assay (EMSAs) were performed as pre-
viously described [19], using [c-33P]-dCTP. Double-stranded DNA oli-
gonucleotides were end-labelled with [c-33P]-dCTP. Binding reactions
were carried out for 45 min on ice using 20 lg of NEs, 0.5 ng of probe,
and 2 lg dI/dC in the binding buﬀer. Supershifts were obtained adding
2 lg anti-HA (Roche). Competition assays were 100-fold molar excess
of unlabelled oligonucleotides. Samples were submitted to electropho-
resis on a cold 5% polyacrylamide gel in 0.5X TBE at 120 V. Dried gels
were analysed by Phosphorimager and ImageQuant v5.2 (Molecular
Dynamics).
2.7. Non-radioactive in situ hybridisation
Heads of CD1 embryos and mice were ﬁxed in 4% formaldehyde and
cryosectioned (7- to 10-lm-thick frozen sections). In situ hybridisation
(ISH) was performed as previously described [20]. Hybridisation solu-
tion contained 5X SSC, 50% formamide, 0.2 mg/ml yeast tRNA,
100 lg/ml heparin, 1X Denhardt’s solution, 0.1% Tween 20 and
5 mM EDTA, and hybridisation was performed at 68 C. The Atoh1
probe was a gift of P. Gray, Department of Neurobiology, Harvard
Medical School.Table 1
Genes upregulated by ATOH1 in U2OS cells at 8 and 24 h
Probe Gene Complem
blast ana
49052_at – CDNA FLJ14388 ﬁs, clone
HEMBA1002716
WISP1;
inducible
pathway
34143_at CHRNA1 Cholinergic receptor, nicotinic,
alpha polypeptide 1
82144_at – CDNA FLJ14388 ﬁs, clone
HEMBA1002716
WISP1;
inducible
pathway
39268_at KCNF1 Potassium voltage-gated
channel, subfamily F, member 1
41475_at NINJ1 Ninjurin 1
41045_at SECTM1 Secreted and transmembrane 1
77603_at SHF Src homology 2 domain containing F
63992_at SNAI2 Snail homolog 2
49633_at HES6 Hairy and enhancer of split 6
36533_at PTGIS Prostaglandin I2 (prostacyclin)
synthase
51162_at SYT7 Synaptotagmin VII
37117_at ARHGAP8 Rho GTPase activating protein 8
aMean of two experiments.3. Results
3.1. Gene expression proﬁling in cells expressing ATOH1
We assessed gene expression in U2OS cells expressing Atoh1
under the control of a TET-oﬀ system using the HG-U95
Aﬀymetrix GeneChips. Twenty-four hours after ATOH1
induction, 73 genes showed increased expression (Supplemen-
tary Table 1). Eleven of them showed upregulation within
8 h (Table 1). We used RT-PCR to assess their expression in
two independent Atoh1-U2OS clones at 24 h and conﬁrmed
that they are all upregulated in the presence of ATOH1 (data
not shown; see Fig. 1a for HES6). We then analysed the time-
course of their expression, measuring every 2 h after TET re-
moval. We were able to detect upregulation as early as 2 h
after Atoh1 induction for four genes: CHRNA1, SECTM1,
SNAI2, and HES6 (Table 1 and Fig. 1b for HES6), indicating
a fast regulation by ATOH1.
The induction of HES6 as an immediate response to
ATOH1 expression in the U2OS cells together with its colocal-
ization with Atoh1 in HC [11] suggest it is directly regulated by
ATOH1 during inner ear development.
3.2. ATOH1 regulates Hes6 expression
We found that Hes6 is expressed in the cochlea from E14.5
(data not shown; [11]) in the zone of non-proliferating cells, to
early post-natal stage in HC (Fig. 2). Hes6 was expressed in
hair cells of the apex at P1, a time when Atoh1 begins to be
downregulated. At the base, Atoh1 was silenced and Hes6
was still weakly expressed. No expression of Atoh1 nor Hes6
was detected at P3. Therefore, Hes6 mRNA expression closely
follows that of Atoh1 in HC, in agreement with the hypothesis
that Hes6 is directly regulated by ATOH1.
The 1.2 kb sequence located 5 0 upstream of the HES6 tran-
scription start site (human NM_018645, NT_005120; mouse
NM_019479, NT_078297) showed 38% identity between
mouse and human (Fig. 3). It contained a TATA box and ﬁve
conserved ATOH1 putative binding sites (E boxes), here
named E1 to E5. E1–E4 are clustered in 1130 to 860 baseentary
lysis
24 ha 8 h Onset of
upregulation
by ATOH1(h)
Log
ratio
p Value Log
ratio
p Value
WNT1
signaling
protein 1
5.4 0.000001 4.4 0.000006 6
4.6 0.000010 3.2 0.000014 2
WNT1
signaling
protein 1
4.4 0.000001 2.4 0.000143
3.5 0.000352 2.8 0.000023 8
2.9 0.000000 2.9 0.001226 6
2.6 0.000001 2.5 0.000050 2
2.5 0.000000 1.4 0.000001 6
2.5 0.000001 1.4 0.000000 2
2.1 0.000000 1.7 0.000003 2
2.0 0.000059 1.9 0.000499 4
1.7 0.000008 1.2 0.000608 8
1.6 0.000015 1.4 0.000333 8
+ ATOH1 +
HES6
GAPDH
- +-
4 h2 ha b
ATOH1 -
HES6
GAPDH
24 h
Fig. 1. RT-PCR showing the induction of HES6 expression by
ATOH1 in U2OS cells. (a) HES6 expression after 24 h in the absence
() or presence (+) of ATOH1. (b) HES6 mRNA was detected both 2
and 4 h after the induction of ATOH1 expression. The housekeeping
gene GAPDH was used as a RT control.
Fig. 2. In situ hybridisation showing Hes6 and Atoh1 expression in
cochlear hair cells at post-natal stages P1 and P3 (adjacent sections).
Scale bars 10 lm.
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(167 bp).
We placed the HES6 promoter in front of a luciferase repor-
ter gene and performed transient transfection in Atoh1-U2OS
cells. ATOH1 expression caused an increase in luciferase activ-
ity (Fig. 4, lane 2). This activation was lost with a shorter pro-
moter construct containing only E5 (lane 3), indicating that E5
is not suﬃcient for regulation by ATOH1. When E1, E2 or E4
was mutated in the promoter, there was a signiﬁcant loss of the
luciferase activity (compare lanes 4, 5, 7 to lane 2). On the con-
trary, E3 alteration alone or together with E4 did not aﬀect thehuman TGGGGTCCGAGAAGGCGTCTCCCGTTCCGGCTCCTCCACACAGCGTCTGGACTGACGCCGGGGCAGGAGCCGGGCAGGGGTCCCCAGGACGCTGCCCGAG -1105 
mouse T-----CTAAAGCAGCAGCCGAAATCCAAGAACGCTGGAGCAGAGCCAGGGGTTCCGAGGGGGCGCG---CGCGCGCGCACACACA------CACACACA -1184 
      *     *  *    **  *     * *  *  *       *** * * **  *  **  *****  *   ** **  *    * **        * *    
 
human GGCGCGGCCCCACCGCCCACGCACCCCGCCCGCGGCCAAGAGGAACCCAGCAGATGGGCGGCCCGCCGCGATGGGGGAGTCGCGGGCGTCTGGCCGGGAC -1005 
mouse CACACACACACAC-ACACACACACCCCTCCCGCGGCGAGGCAGGGCC-GGCAGATGGACCGCCGACGACGCGGGG-----CTTGGGCGTCTGGCCGACAC -1091 
        * *   * ***  * *** ****** ******** * *  *  **  ******** * ***  *  **  ***     *  *************  ** 
 E1 
human AAGCG--CCCGCCGCCTGCCCGCCGGACAAAGGGTGCGAGACAAAGGCGCGGCCAACACCTGTCGCTCTTGGCGCGGCCGCCGCTTTTCTCGCTTTTCTC -907 
mouse AGGCGTGCCTGTTGCA-GCCTGCAGGACAAAGCCAGCTAGACAAAGGCGCGGCCAACACCTGTCGCTCCTGGC-CGGCC--------TGCCGCTTTTCTC -1001 
      * ***  ** *  **  *** ** ********   ** ****************************** **** *****        *  ********** 
 E2 
human CGCCGAAGCGGCCGCAGCTGCCAACTGTCACGGGCATCAAGTTAC-AGGACCAGACGGCAGCTTCGGC---------------------------GGGCC -835 
mouse TGCGGAAGCGGCTGCAGCTGCCAACTGTCACGGGCATCAAGTTACTGGGGCCAGACAGCAGCCTCGGCCTGCAGGAACCAAGAATAGAAGGGGGAGGAGC -901 
       ** ******** ********************************  ** ****** ***** *****                           **  * 
E3 E4 
human TGGGAGGC----GGGGCGCGGAGGACGAGG-------AGGGGA--------GGAGGGAGGCGGGCG-----GGGGGCAGTGGAA--GGGAGGGAGGGGGC -761 
mouse TGAGAGGGACTGGGGGTAGTGGGGATGGGGGACTCTAAGGGGACTCGCGGGGAAGGGAGGTGAGCGTGGAGAGGGGTTGGGGAACAGGGATGTGTGAGAC -801 
      ** ****     ****    * *** * **       ******        * ******* * ***      ****  * ****  **** *   * * * 
 
human CCC------GGGGGCCAAAGGGGACTAGAGGGAGATGGGGGA-GCTCAGAGGGGGGCGGGGCTGGTGACCC-----GCAGAGCCCAGGGGGAGAGCGGCG -673 
mouse CACCGCAAAGAGGATGCGGAGGAACTAGAGGGAAATGAGAGGCGCTTAGGCGGGTACGGGG-TGATGAACAAGGAAGGAGAAGCTTGACTGGGGGCAGTT -702 
      * *      * **       ** ********** *** * *  *** **  ***  ***** ** *** *      * ***  *  *   * * ** *   
 
human CGGGCGGG-----------------------------AGCACCCGGGACCCCGCCCCACTAGGACTCCAGTGCTGGCGGAGGGCGGCGTCGGGG--GTCC -604 
mouse GGGGTGGGGTTAAAATAGACAAGGTAGTGGTTGGGTAAGTGACTTAGAGCACAGAGAAATAGAGATTTAGTAAGAACGACCGCGGACCTTGGAGTAAGAA -602 
       *** ***                             **   *   ** * *     * ***   *  ***     **   *  * * * ** *       
 
human GGCCC--GGCGTCTGGACGAGTCCGGAAGAA-ACTCAGGGGCCGCCCCGCCACCGCTGCCCAATGGACCC-TGCCTCCCCGGGGCTTGGCAGCCACCCCA -508 
mouse GGTTATAGGTGTCTTAATGGGTCCAAAAGGACACACAAGGGTC---CTGTTCCTGCTGCTAAATTGGCTCGTACTTTCCCCGGACTTTGCACTCTCGCCA -505 
      **     ** ****  * * ****  *** * ** ** *** *   * *   * *****  *** * * * * * * *** ** *** ***  * * *** 
 
human GCCGGGACCTGAAACCCCT-CTAGGTCCAGAGACCGCGGACTTGACTGTGGCTCTGCACACCAGGGACGCATCTCCTGGGGCCAGTG----GCCCCAGCG -413 
mouse CCGGTGACCCGAAGCCCCTTCCAGGTCCCGAGGTCACGGACTTGACTTTGGCACTGCCCTGTCTGAAGTCAGCTC-TGGGACTGGAGCGCTATTCTCGAG -406 
       * * **** *** ***** * ****** ***  * *********** **** **** *     * *  ** *** **** *  * *       *  * * 
 
human CTCAACTCTGGAGGCGCCATCGGCGAAGGAG------GGAAATGAATGAATTAATGGGTGAATGAATGAGTGG-ACGGACGGACGGACGGACGGGTGGAC -320 
mouse AGCACTTTTGGTGAACCAAGGGAAGCAAATGCCCTGTAGGAATGGATGGGTGAAGAGGTGGGTGGAAGGGCGGCATGGATAGATATACGGACCGAAGGAT -306 
        **  * *** *   * *  *  * *   *       * **** ***  * **  ****  ** * * * ** * ***  **   ****** *  ***  
 
human GCCT------------GCTCGCACGCGCGGCAGATCAGTGGTCCTAGAGCAGCAGACGGAGAGAAACAAGCGCGGGCAGGGCCGCAGCTACCCGGGGTCG -232 
mouse GTATAGCTAAGTCCGAGCTTACAGGCA-GGCAGGTCTGGCCTCATAACTCAGCGAAAGGAAGTACAAGCACACCAGCAAGAGAGAAGCCG---GAGGTCA -210 
      *  *            ***  ** **  ***** ** *   ** **   ****  * ***   * *    * *  *** *   * ***     * ****  
 
human CCGCCCCGGTGCCGCCCCCGCGGGGGTCTAGGGAAGGCCGGGCTGGGGGCCCCGCCTAGCTCAGCCAGCTGCCCGACCGCCAGAGCCGCTGGGCCGGACA -132 
mouse CTGCCCAGGAGTCCTGCCCGGCCTAAGTGGCAGGAGGTCTGGCTGTGGGCTCCGCC-----CCGCCAGCTGCCAGA------GACCCGCGGGGCCTGACA -121 
      * **** ** * *   ****            * *** * ***** **** *****     * ********** **      ** **** ***** **** 
      E5 
human AAGCGCGCTGCCCCGATTGGCTGCAGCGCGCCTCGCGGTCGGCCGCCCCGGGCCCGCGCGGCCAATCGGCGCATTGAGATGCAAATAAGCGGCTATAAAA -32 
mouse AAGCGCGCCGCTCTCATTGGCTACAGGCTGCCTCACGGCTGGCCTCTCCGACCACGCACAGCCAATCGGTGCATTGACATGTAAATAAGTTGCTATAAAA -21 
      ******** ** *  ******* ***   ***** ***  **** * ***  * *** * ********* ******* *** *******  ********* 
 
human GGGGCGGGACCGCGGCGGGCCGGAAGCCGCGAGGAGCGCGGACGGCTGGGCTGCTGCTGGGCGGCCGCGGGGCAGCGGAGGGCGCCGGCACTCCGGTCCC 2068 
mouse TGGGCGGGGTCCCG-CGGGCCGGAAGACTC--------CGGAGAGCTAG--------TGGG--GCCTCCGGGCTGCGA--------------------CC 2040 
       *******  * ** *********** * *        ****  *** *        ****  *** * **** ***                     ** 
Fig. 3. ClustalW (EMBL-EBI http://www.ebi.ac.uk/clustalw/) alignment of the promoter of HES6 between mouse and human. Conserved E boxes
are highlighted. The TATA box and the transcription start sites are indicated in bold. The EMSA probes are underlined.
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Fig. 4. HES6-promoter-mediated luciferase activation by ATOH1. The constructs used were: (1) empty luciferase vector; (2) HES6 promoter
1.2 kb; (3) proximal promoter 750 bp; (4–8) E1, E2, E3, E4, E3 + E4 mutated respectively. The luciferase activity is shown as the fold induction
upon ATOH1 expression in U2OS stably transfected cells. Bars represent standard errors.
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activates HES6 transcription through three conserved clus-
tered E boxes: E1, E2 and E4.Fig. 5. Physical interaction between ATOH1/E47 and the E boxes of the prom
cells transfected with empty vector, Atoh1-HA, E47, Atoh1-HA + E47. Ato
supershift (arrowhead) when incubated with an anti-HA antibody. Competiti
no shift when E1 was mutated (E1*). (b) Interaction between ATOH1-HA/E4
by the supershift (arrowhead). (c) Comparison of the shifts obtained on the
(E3_E4). A higher molecular weight shift is indicated by a white arrow. * I
unbound probe is not shown.To determine whether this regulation occurs through direct
binding of ATOH1 to the E boxes, we performed EMSAs.
When the probe containing the E1 box was incubated with aoter of HES6 by EMSA. (a) Interaction between probe E1 and NE of
h1-HA/E47 interaction on the probe resulted in a shift (arrow) and a
on (comp) was performed using a 100· excess of cold probe. There was
7 and the probe containing both E3 and E4 (E3/E4) (arrow) conﬁrmed
E3/E4 probe and the probe containing E3 and E4 separated by 13 bp
ndicates that the corresponding E box is mutated on the probe. The
D. Scheﬀer et al. / FEBS Letters 581 (2007) 4651–4656 4655NE containing ATOH1 and E47, a speciﬁc mobility shift was
observed (Fig. 5a, arrow). Supershift assays showed the spe-
ciﬁc binding of ATOH1 to the probe (arrowhead). ATOH1/
E47 heterodimers were no longer able to bind to the probe
when the E box E1 was mutated (E1*). Similar results were
obtained with the E2 probe (data not shown).
E boxes E3 and E4 are separated by only 1 bp. When the
EMSA probe containing these two E boxes was incubated
with a NE containing ATOH1/E47, a band shift was
observed (Fig. 5b, arrow). Preincubation with the antibody
directed against HA-tagged ATOH1 resulted in a supershift
(arrowhead). The shift and supershift were conserved when
only one E box was mutated but was lost when both were
mutated, indicating that the heterodimers can bind to either
E3 or E4. However, the close proximity of the two E boxes
could result in steric hindrance and prevent the binding of
two ATOH1/E47 heterodimers (one to each E box), as we
found for the CHRNA1 promoter [21]. We therefore designed
a probe where E3 and E4 are separated by 13 bp (Fig. 5C,
E3_E4). The shift was still present, and we observed a sup-
plementary shift of higher molecular weight (white arrow).
This higher shift was speciﬁcally abolished when only one
of the E boxes was mutated, indicating that it is likely to
result from the binding of two heterodimers. This result
indicates that steric hindrance prevents the binding of two
ATOH1/E47 heterodimers to the E3 and E4 E boxes of the
native sequence.4. Discussion
Our ﬁndings show that ATOH1 directly activates the tran-
scription of HES6 in vitro through binding to three clustered
E boxes (E1, E2 and E4) located in its promoter. The expres-
sion proﬁle of Hes6 closely follows that of Atoh1 and therefore
the basal-to-apical gradient of diﬀerentiation of cochlear HC
[3]. This observation, as well as the direct regulation shown
in vitro, indicates that ATOH1 is likely to be the main regula-
tor of Hes6 expression in HC in vivo. We also detected Hes6
mRNA in the spiral ganglia during embryogenesis (data not
shown) in agreement with its earlier expression in delaminating
neurons of the E9.5 otocyst [22].
Several other class 2 bHLH have the capability to regulate
Hes6 expression: Ngn1 or Xath3 injection promotes Hes6
upregulation in Xenopus [14], and Hes6 upregulation follows
that of MyoD during muscle regeneration [23]. Moreover,
MASH1 can bind on the same clustered E boxes than ATOH1
[24], indicating that this region is possibly involved in multiple
bHLH regulations of Hes6.
In the inner ear, HES6 might be involved in the diﬀerentia-
tion of HC. In fact, it promotes neuronal diﬀerentiation in the
neural plate [14], the retina [15] and in the cortex [25,26]. How-
ever, unlike Atoh1, Hes6 overexpression in the Ko¨lliker’s
organ of post-natal rat cochlea does not lead to HC diﬀerenti-
ation [11]. As HES6 has been shown to act synergistically with
proneural genes [16], lack of expression of ATOH1 in the tar-
geted cells might prevent a HES6-mediated trans-diﬀerentia-
tion into HC. Our results show that a bHLH-factor cascade
similar to that observed in neuronal tissues [27] may take
place in the inner ear during development of the sensory epi-
thelia.Acknowledgements:We thank R. Palmer and D.-S. Zhang for technical
assistance (U2OS cells) and P. Gray for the Atoh1 probe. This work
was supported by the Avenir project at INSERM and Grant
DC002281 from the NIH/NIDCD to DPC. DS is a recipient of a IN-
SERM/Ile de France and Fondation pour la Recherche Medicale fel-
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Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2007.08.
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